Exclusive: Regulator extends part-suspension of licence to July 2024 after IT blunder caused incorrect dosage of cancer treatment
A private health company paid millions by the NHS has failed to fix safety defects that led to the death of a cancer patient, the Guardian can reveal.
Three patients were hospitalised and a fourth died when they were given the wrong doses of a powerful chemotherapy after a catastrophic IT failure at the medicine manufacturing unit of Sciensus in April this year.
